143 related articles for article (PubMed ID: 20418070)
1. Maternal and fetal blood levels of moxifloxacin, levofloxacin, cefepime and cefoperazone.
Ozyuncu O; Nemutlu E; Katlan D; Kir S; Beksac MS
Int J Antimicrob Agents; 2010 Aug; 36(2):175-8. PubMed ID: 20418070
[TBL] [Abstract][Full Text] [Related]
2. Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime.
Ozyüncü O; Beksac MS; Nemutlu E; Katlan D; Kir S
J Obstet Gynaecol Res; 2010 Jun; 36(3):484-7. PubMed ID: 20598025
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics of moxifloxacin and levofloxacin simulating human serum and lung concentrations.
Schubert S; Dalhoff A; Stass H; Ullmann U
Infection; 2005 Dec; 33 Suppl 2():15-21. PubMed ID: 16518707
[TBL] [Abstract][Full Text] [Related]
4. Cross-over assessment of serum bactericidal activity of moxifloxacin and levofloxacin versus penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in healthy volunteers.
Hart D; Weinstein MP
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):375-8. PubMed ID: 17449210
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
Fuhrmann V; Schenk P; Jaeger W; Ahmed S; Thalhammer F
J Antimicrob Chemother; 2004 Oct; 54(4):780-4. PubMed ID: 15347636
[TBL] [Abstract][Full Text] [Related]
6. Penetration of moxifloxacin and levofloxacin into cancellous and cortical bone in patients undergoing total hip arthroplasty.
Metallidis S; Topsis D; Nikolaidis J; Alexiadou E; Lazaraki G; Grovaris L; Theodoridou A; Nikolaidis P
J Chemother; 2007 Dec; 19(6):682-7. PubMed ID: 18230551
[TBL] [Abstract][Full Text] [Related]
7. Serum bactericidal activities of moxifloxacin and levofloxacin against aerobic and anaerobic intra-abdominal pathogens.
Stein GE; Schooley S; Tyrrell KL; Citron DM; Nicolau DP; Goldstein EJ
Anaerobe; 2008 Feb; 14(1):8-12. PubMed ID: 17983770
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
Odenholt I; Cars O
J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats.
Fernández-Varón E; Villamayor L; Escudero E; Espuny A; Cárceles CM
Vet J; 2006 Sep; 172(2):302-7. PubMed ID: 15908243
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and milk penetration of moxifloxacin after intramuscular administration to lactating goats.
Cárceles CM; Villamayor L; Escudero E; Marín P; Fernández-Varón E
Vet J; 2007 Mar; 173(2):452-5. PubMed ID: 16377219
[TBL] [Abstract][Full Text] [Related]
11. Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
Polachek H; Holcberg G; Sapir G; Tsadkin-Tamir M; Polachek J; Katz M; Ben-Zvi Z
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):61-5. PubMed ID: 16154040
[TBL] [Abstract][Full Text] [Related]
12. High doses of levofloxacin vs moxifloxacin against staphylococcal experimental foreign-body infection: the effect of higher MIC-related pharmacokinetic parameters on efficacy.
Murillo O; Pachón ME; Euba G; Verdaguer R; Tubau F; Cabellos C; Cabo J; Gudiol F; Ariza J
J Infect; 2009 Mar; 58(3):220-6. PubMed ID: 19217166
[TBL] [Abstract][Full Text] [Related]
13. Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection.
Schulte S; Ackermann T; Bertram N; Sauerbruch T; Paar WD
J Chromatogr Sci; 2006 Apr; 44(4):205-8. PubMed ID: 16620519
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue.
Wagner RS; Abelson MB; Shapiro A; Torkildsen G
Arch Ophthalmol; 2005 Sep; 123(9):1282-3. PubMed ID: 16157821
[No Abstract] [Full Text] [Related]
15. Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery.
Metallidis S; Charokopos N; Nikolaidis J; Alexiadou E; Lazaraki G; Koumentaki E; Tsona A; Theodoridis G; Nikolaidis P
Int J Antimicrob Agents; 2006 Nov; 28(5):428-32. PubMed ID: 17034992
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis.
Czock D; Hüsig-Linde C; Langhoff A; Schöpke T; Hafer C; de Groot K; Swoboda S; Kuse E; Haller H; Fliser D; Keller F; Kielstein JT
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1263-8. PubMed ID: 17699357
[TBL] [Abstract][Full Text] [Related]
17. Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies.
Siewert S
J Pharm Biomed Anal; 2006 Jun; 41(4):1360-2. PubMed ID: 16563690
[TBL] [Abstract][Full Text] [Related]
18. In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.
Schafer J; Hovde LB; Simonson D; Rotschafer JC
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):155-61. PubMed ID: 17910998
[TBL] [Abstract][Full Text] [Related]
19. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.
Wacke R; Förster S; Adam U; Mundkowski RG; Klar E; Hopt UT; Drewelow B
J Antimicrob Chemother; 2006 Nov; 58(5):994-9. PubMed ID: 16956903
[TBL] [Abstract][Full Text] [Related]
20. Simple and rapid liquid chromatography method for determination of moxifloxacin in plasma.
Hemanth Kumar AK; Ramachandran G
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(11-12):1205-8. PubMed ID: 19286427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
